Allied Biotech (1780.TWO) Stock Price

Allied Biotech Price

CLOSED
23.05
​
Market closed

Revenue has compounded at 6.4% per year over the past 19 years to 849.51 M TWD. Earnings per share have grown at 25.6% per year over the last 17 years. Allied Biotech's net margin stands at 15.2%, up from 1.9% several years earlier. Allied Biotech currently offers a dividend yield of about 4.34%. The payout ratio is around 74% of earnings. The dividend has grown at 26.0% per year over the past 3 years.

Allied Biotech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Allied Biotech business model & stock analysis

Allied Biotech Corp. engages in the manufacture of carotenoid formulations for food, supplement, feeds, and cosmetics. The company is headquartered in Taipei City, Taipei. The company went IPO on 2010-04-29. The firm's nutraceutical products include healthcare products for human, nutraceutical products for animals, veterinary drugs, pharmaceutical cosmetics and biotechnology products, among others. Its carotenoids are applied in the processing of food and beverage products. Its major products include beta-carotene, canthaxanthin, lycopene, lutein, coenzyme Q10, natural vitamin E and food additives, among others. The firm distributes its products within domestic market and to overseas markets, including the rest of Asia, Europe and the Americas.

Frequently asked questions about Allied Biotech

Converted at the current exchange rate, the Allied Biotech share trades at 0.64 EUR (23.05 TWD).

The revenue cannot currently be calculated for Allied Biotech.

The profit cannot currently be calculated for Allied Biotech.

The P/E ratio cannot be calculated for Allied Biotech at the moment.

The P/S cannot be calculated for Allied Biotech currently.

The Eulerpool Quality Score for Allied Biotech is 4/10.

The ISIN of Allied Biotech is TW0001780005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Allied Biotech is 1780.TWO. The ticker symbol is used to trade Allied Biotech shares on the stock exchange.

Fair ValueTerminal
21.21 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
6.53 M TWD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Apr 29, 2010
ISIN
TW0001780005
Cusip
Y0089D108
Market capitalization
2.22 B TWDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
12.16
P/B Ratio
1.80
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
10.20 %
Dividend
Dividend yield
4.34 %
Payout Ratio
74.34 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
4 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
21.00 %
Last updated Oct 28, 2026, 5:53 PM

Allied Biotech Peer Group

Allied Biotech FIGI

1780:TT (Taipei Stock Exchange) · BBG000QRR0R2